NERVE MONITORING SYSTEM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Nerve Monitoring System Market, By Product (Nerve Monitor, Electrodes, Probes, Accessories), By Technology (Electroencephalogram (EEG), Electromyography (EMG), Electrocorticography (ECOG), Evoked Potential (EP)), By Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
In April 2023, Neuspera Medical, a medical device company, announced that it had received U.S. Food and Drug Administration (FDA) approval for the next-generation Neuspera ultra-miniaturized system. The system comprises a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.
In December 2022, WISE S.r.l., a medical device company, announced that it had received an approval from U.S. Food and drug Administration for its WISE Cortical Strip, a single-use device for neuromonitoring. The new device has been designed for Intra Operative Neurophysiological Monitoring (IONM) from the surface of the brain.
In April 2022, Assure Holdings Corp., an intraoperative neuromonitoring company, signed a group purchasing agreement ('GPO') for intraoperative neuromonitoring services with Conductiv, the only end-to-end third-party lifecycle improvement company. The agreement allows Conductiv members, which includes 500 hospitals and surgery centers and more than 50 health systems, to take advantage of special pricing and pre-negotiated terms for Assure's Joint Commission accredited intraoperative neuromonitoring services.
In February 2022, Medtronic, a global medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for InterStim X, the personalized system to deliver sacral neuromodulation (SNM) therapy
In October 2020, Medtronic, a global medical technology company, announced that it had received an approval from U.S. Food and Drug Administration (FDA), for the NIM Vital nerve monitoring system that enables physicians to identify, confirm, and monitor nerve function to reduce the risk of nerve damage during head and neck surgery. The NIM Vital system uses proprietary technology to provide detailed intraoperative nerve condition data that informs surgical strategy, increases operative efficiency and precision, and helps protect patients' quality of life.